The Valley Desk

NCT03745716 · Interventional trial

APR-246 & Azacitidine for the Treatment of TP53 Mutant Myelodysplastic Syndromes (MDS)

Overall registry status Completed

Phase 3

Conditions MDS

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov